Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Double-blind Placebo Controlled, Randomized, Parallel-group, Phase II study in subjects with relapsing forms of Muiltiple Sclerosis to evaluate the effects of two doses of CDP323 over 24 weeks with a rater blind MRI follow up over 12 weeks
Berger, Joseph
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/1/07
→
10/31/11
View all
View less